首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of addiction medicine

缩写:J ADDICT MED

ISSN:1932-0620

e-ISSN:1935-3227

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1848
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Justin C Strickland,Cecilia L Bergeria,Andrew S Huhn et al. Justin C Strickland et al.
Objectives: The prevalence of xylazine, an agonist at the alpha-2 adrenergic receptor often used in veterinary medicine, has increased in the illicit opioid drug supply. Case series and survey data suggest that xylazine m...
Bryant Shuey,Fang Zhang,Stephanie Argetsinger et al. Bryant Shuey et al.
Objective: Determine whether employer-mandated transitions from low- to high-deductible health plans (HDHPs) are associated with delays in opioid use disorder (OUD)-related care presentations. Cost-sharing may negatively ...
Andrew Stolbach,Rachel Culbreth,Alyssa Falise et al. Andrew Stolbach et al.
Objectives: Medetomidine is an alpha-2 adrenoreceptor agonist approved only for veterinary sedation and was reported in the US illicit drug supply starting in 2022. Our aim was to determine the prevalence of medetomidine ...
Yi-Shin Grace Chang,Vanessa M McMahan,Luke N Rodda et al. Yi-Shin Grace Chang et al.
Objectives: Deaths attributed to stimulants in the United States are largely driven by fentanyl coinvolvement. We sought to compare antecedents of acute stimulant deaths involving fentanyl to those that do not involve opi...
Kaitlyn Kasemodel,Spencer Ilstrup,Jaymie Avenido et al. Kaitlyn Kasemodel et al.
Xylazine, an alpha-2 adrenergic agonist veterinary sedative, has emerged as a frequent adulterant in illicit opioids, contributing to the ongoing "tranq dope" crisis. Its effects on human pregnancy are largely unknown, posing new challenges...
Patience M Dow,Miriam George,Andrew R Zullo et al. Patience M Dow et al.
Objectives: Prior studies have documented rising rates of referrals to skilled nursing facilities (SNFs) for hospitalized patients with opioid use disorder (OUD). However, the care transitions and survival of people with ...
Raagini Jawa,Mariska Goswami,Samia Ismail et al. Raagini Jawa et al.
Background: Drug use-related stigma amplifies the harms faced by people who use drugs (PWUD). Media often dehumanizes PWUD, particularly those using xylazine, a veterinary sedative and opioid adulterant, by labeling them ...
Peter J Na,Anica Pless Kaiser,Li Yan McCurdy et al. Peter J Na et al.
Objectives: Loneliness is a pervasive public health problem, especially among individuals with problematic substance use (PSU). To date, however, scarce research has examined the prevalence and correlates of loneliness in...
Marlene C Lira,Lauren E Hendy,Judith I Tsui et al. Marlene C Lira et al.
Objectives: Individuals receiving treatment for opioid use disorder (OUD) represent a key population for hepatitis C diagnosis and treatment. Integrating hepatitis C treatment within telemedicine addiction care offers a n...